Your browser doesn't support javascript.
loading
A systematic review of surgical biopsy for LCIS found at core needle biopsy - do we have the answer yet?
Buckley, E S; Webster, F; Hiller, J E; Roder, D M; Farshid, G.
Afiliación
  • Buckley ES; School of Population Health, Division of Health Sciences, University of South Australia, GPO Box 2471, Adelaide, South Australia, Australia. Electronic address: elizabeth.buckley@mymail.unisa.edu.au.
  • Webster F; Cancer Australia, Locked Bag 3, Strawberry Hills, New South Wales 2012, Australia. Electronic address: Fleur.Webster@canceraustralia.gov.au.
  • Hiller JE; Faculty of Health Sciences, Australian Catholic University, Locked Bag 4115, Fitzroy MDC, Fitzroy, Victoria 3065, Australia; School of Population Health, University of Adelaide, 178 North Terrace, Adelaide, South Australia 5000, Australia. Electronic address: Janet.Hiller@acu.edu.au.
  • Roder DM; School of Population Health, Division of Health Sciences, University of South Australia, GPO Box 2471, Adelaide, South Australia, Australia. Electronic address: David.Roder@unisa.edu.au.
  • Farshid G; BreastScreen SA, 1 Goodwood Rd, Wayville, South Australia 5034, Australia. Electronic address: Gelareh.Farshid@health.sa.gov.au.
Eur J Surg Oncol ; 40(2): 168-75, 2014 Feb.
Article en En | MEDLINE | ID: mdl-24246610
BACKGROUND: The natural history of lobular carcinoma in-situ (LCIS) suggests that women are at increased risk of subsequent invasive breast cancer. Questions of effective management for women with this lesion have led to the need for evidence-based guidance and, in particular, guidance regarding management after LCIS is found at core needle biopsy (CNB). METHODS: A systematic review was conducted to determine the most appropriate management for women with LCIS found at CNB. A comprehensive search of the scientific literature was conducted to identify the literature pertaining to this population. Critical appraisal of the literature, data extraction and a narrative synthesis of the results were conducted. The outcome of interest was upgrade of diagnosis to invasive breast cancer or ductal carcinoma in-situ (DCIS). RESULTS: Sparse data, with limited generalisability and considerable uncertainty, are available for women with LCIS at CNB. Nine studies were identified that met pre-specified inclusion criteria. The reported estimates of upgrade of diagnosis from LCIS to invasive breast cancer or DCIS ranged from 2% to 25%. The body of evidence was limited by its retrospective nature, risk of selection bias and poor generalisability to all women with LCIS at CNB. Further, higher quality research is required to determine the best approach for women with LCIS at CNB with any certainty.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma in Situ / Carcinoma Lobular Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Eur J Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma in Situ / Carcinoma Lobular Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Eur J Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido